4.6 Article

A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants

期刊

AMERICAN JOURNAL OF PSYCHIATRY
卷 178, 期 1, 页码 77-86

出版社

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2020.20010015

关键词

-

资金

  1. Baily Thomas Charitable Trust [2315/1]
  2. Brain Canada Foundation
  3. Canada Research Chair in Genetics of NeurodevelopmentalDisorders
  4. Canadian Institute of Health Research [400528/159734]
  5. Health and Care Research Wales [507556]
  6. Medical ResearchCouncilCentre [G0801418]
  7. Medical Research Council [G0800509, 1499282]
  8. NIMH [5UO1MH101724, MH064824, RO1 MH085953, U01MH101719]
  9. Simons Foundation
  10. Simons Foundation Autism Research Initiative
  11. Swiss National Science Foundation [PMPDP3_171331]
  12. United Kingdom Medical Research Council
  13. Medical Research Foundation [MR/L011166/1, MR/N022572/1]
  14. Waterloo Foundation [WF918-1234]
  15. Wellcome Trust [505714]
  16. Wellcome Trust ISSF
  17. Wellcome Trust Strategic Award
  18. European COST Action, Maximizing Impact of research in NeuroDevelopmental DisorderS (MINDDS) [CA16210]
  19. MRC [MR/N022572/1, MR/T033045/1, MR/L011166/1] Funding Source: UKRI

向作者/读者索取更多资源

This study investigated the clinical presentation of autism in individuals with specific CNVs associated with high risk of autism as well as those with autism of heterogeneous etiology. Results showed differences in autism symptom severity, subdomain profile, and IQ profile among different genetic variant groups, with high variability within groups and low variability between groups. Many CNV carriers did not meet full diagnostic criteria for autism but still showed elevated levels of autistic traits when clinical cutoff scores were applied.
Objective: Certain copy number variants (CNVs) greatly increase the risk of autism. The authors conducted a genetics-first study to investigate whether heterogeneity in the clinical presentation of autism is underpinned by specific genotype-phenotype relationships. Methods: This international study included 547 individuals (mean age, 12.3 years [SD=4.2], 54% male) who were ascertained on the basis of having a genetic diagnosis of a rare CNV associated with high risk of autism (82 16p11.2 deletion carriers, 50 16p11.2 duplication carriers, 370 22q11.2 deletion carriers, and 45 22q11.2 duplication carriers), as well as 2,027 individuals (mean age, 9.1 years [SD=4.9], 86% male) with autism of heterogeneous etiology. Assessments included the Autism Diagnostic Interview-Revised and IQ testing. Results: The four genetic variant groups differed in autism symptom severity, autism subdomain profile, and IQ profile. However, substantial variability was observed in phenotypic outcomein individual genetic variant groups(74%-97% of the variance, depending on the trait), whereas variability between groups was low (1%-21%, depending on the trait). CNV carriers who met autism criteria were compared with individuals with heterogeneous autism, and a range of profile differences were identified. When clinical cutoff scores were applied, 54% of individuals with one of the four CNVs who did not meet full autism diagnostic criteria had elevated levels of autistic traits. Conclusions: Many CNV carriers do not meet full diagnostic criteria for autism but nevertheless meet clinical cutoffs for autistic traits. Although profile differences between variants were observed, there is considerable variability in clinical symptoms in the same variant.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据